$ cat jobs/senior-scientist-cardiac-modeling-insitro-c9340714e9e6.json
Senior Scientist, Cardiac Modeling
THE OPPORTUNITY insitro is a physical AI company dedicated to unlocking causal human biology and accelerating the delivery of better medicines to patients. Our unique Virtual Human™ platform identifies novel, high-impact genetic intervention points, which our TherML™ platform translates into therapeutics—whether small molecules, biologics, or oligos. With multiple programs in metabolic disease and neuroscience advancing toward the clinic, and our first IND submission slated for the second half of this year, we are at a pivotal inflection point. We are seeking a Senior Scientist to join our cardiac disease biology team. In this role, you will own the development and application of iPSC-derived cardiomyocyte (iPSC-CM) models to study the genetic and molecular underpinnings of cardiovascular disease — working at the intersection of human stem cell biology, cardiac physiology, and scalable experimental platforms to generate the datasets that fuel our ML-driven drug discovery efforts. You will design and execute experiments, optimize differentiation and assay workflows, and partner closely with ML scientists, computational biologists, and chemists to connect cellular phenotypes to disease mechanisms and therapeutic targets. Based in South San Francisco, this position reports directly to Vice President, Cardiometabolic Disease - Translational Genetics and requires you to be onsite at our South San Francisco office 5 days per week. RESPONSIBILITIES iPSC-CM Platform & Model Development - Differentiation & QC: Lead the generation, characterization, and maintenance of iPSC lines and their differentiation into cardiomyocytes, with rigorous quality control at each stage of the pipeline - 2D & 3D Formats: Design, implement, and optimize iPSC-CM assays in both 2D monolayer and 3D/engineered heart tissue (EHT) formats, with a focus on scalability and data quality - Genetic Disease Models: Build and apply isogenic iPSC-CM disease models — including CRISPR-edited lines carrying dise